62032-105 : Obagi-c Rx System C-therapy 40 mg/g Topical Cream
NDC: | 62032-105 |
Labeler: | Omp, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Obagi-c Rx System C-therapy Skin Lightening With Vitamins C and E |
Dosage Form: | Topical Cream |
Rev. Date: |
NDC Package Codes:
- 62032-105-36: 57 G IN 1 BOTTLE, PLASTIC (62032‑105‑36)
Active Ingredients:
- Hydroquinone
Dosage Strength:
- 40 mg/g
Pharmaceutical Classes:
- Melanin Synthesis Inhibitor [EPC]
- Melanin Synthesis Inhibitors [MoA]
- Depigmenting Activity [PE]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 62032-104Next: 62032-106 >
Related Discussions:
How Many Minutes Hours Is Active Ingredient Hydroquinone Effective
After hydroquinone is applied to face, how long is that ingredient active on the skin? Minutes/hours?c ## Even though hu... 1 reply
After hydroquinone is applied to face, how long is that ingredient active on the skin? Minutes/hours?c ## Even though hu... 1 reply
does melas cream of eli pharmaceutical contains hydroquinone
I need to know the above contents for melascream. as I need to the contents for melas cream ## Hello, Supric! How are yo... 3 replies
I need to know the above contents for melascream. as I need to the contents for melas cream ## Hello, Supric! How are yo... 3 replies
hydroquinone
Sir can we give expiry of 5 yrs fr hydroquinone sunblock creamspl...
Sir can we give expiry of 5 yrs fr hydroquinone sunblock creamspl...
hydroquinone cream
helps fade excess pigment. pronounced dark spots. get prescription strenght from a dermatologist...
helps fade excess pigment. pronounced dark spots. get prescription strenght from a dermatologist...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.